If you need more lookups,
subscriptions start at $34 USD/month.
David Chaplin Location
United Kingdom
David Chaplin Work
Visiting Research Professor, Department of Chemistry and Biochemistry @ (March 2014 - Present)
Director @ FAST BIOPHARMA LTD (June 2016 - Present)
Member Board of Directors @ PHusis Therapeutics Inc (December 2012 - Present)
Director @ Aston Biopharma Ltd (July 2013 - February 2019)
Director and CSO @ (May 2015 - January 2018)
Member Board of Directors @ Smart Matrix Ltd (January 2012 - September 2017)
President and CEO @ OXiGENE, Inc. (April 2014 - May 2015)
CSO @ OXiGENE (April 2001 - September 2011)
VP ONCOLOGY @ (September 1998 - March 2001)
GROUP HEAD @ (March 1992 - September 1998)
Senior Scientist @ (August 1981 - March 1993)
Head of Oncology @ XENOVA (March 1990 - March 1992)
David Chaplin Education
University of London
Ph.D (CANCER BIOLOGY)
1978-1981
University of Southampton
M.Sc (Pharmacology)
1977-1978
University of Essex
B.Sc (Chemistry)
1974-1977
David Chaplin Skills
Biotechnology
CRO
Cancer
Clinical Development
Clinical Pharmacology
Clinical Trials
Drug Development
Drug Discovery
Infectious Diseases
Life Sciences
Lifesciences
Oncology
Pharmaceutical Industry
Toxicology
David Chaplin Summary
David Chaplin, based in United Kingdom, is currently a Visiting Research Professor, Department of Chemistry and Biochemistry at Baylor University. David Chaplin brings experience from previous roles at FAST BIOPHARMA LTD, PHusis Therapeutics Inc, Aston Biopharma Ltd and Mateon Therapeutics. David Chaplin holds a 1978 - 1981 Ph.D in CANCER BIOLOGY @ University of London. With a robust skill set that includes Biotechnology, CRO, Cancer, Clinical Development, Clinical Pharmacology and more.
Looking for a different David Chaplin?
Find contact details for 700 million professionals.